cvs caremark

Overall, retail sales have sputtered in recent reports. But not all is doom and gloom in the sector; here are seven retail stocks that are on a tear. All of them hit 52-week highs yesterday, and all are up more than 20% since the beginning of the year (or in one case, since its IPO earlier this...

“This month we have decided to take a look at drugstore market share changes over the last few years across the top TV markets in the U.S.,” Jefferies wrote in a report. “As the industry consolidates, larger players such as CVS Caremark (NYSE: CVS) and Walgreens (NYSE: WAG) continue to gain share....

Morgan Stanley is out with its report today on CVS Caremark (NYSE: CVS), maintaining Equal-weight. In a note to clients, Morgan Stanley writes, "The California Public Employees' Retirement System announced after the close that it has awarded a 3 year contract worth $565M annually to CVS/ Caremark...

Walgreen (NYSE: WAG) will be reporting its third-quarter fiscal 2011 results tomorrow, June 21, before the opening bell. Analysts are looking for the drug store operator to post earnings of $0.62 per share on revenues of $18.3 billion. That is up from $0.51 per share and $17.2 billion in the same...

J.P. Morgan is out with its report today on CVS Caremark (NYSE: CVS), maintaining Overweight. In a note to clients, J.P. Morgan writes, "Our rating on CVS Caremark is Overweight. We are a believer in the integrated PBM-retail pharmacy model, and believe the company should gain traction in the...

As part of CVS Caremark (NYSE: CVS) Week, J.P. Morgan is discussing the company's “integrated offering.” “Given its unique position, the company has been able to develop unique programs to lower costs and improve outcomes,” J.P. Morgan writes. “Programs such as Maintenance Choice have had a...

J.P. Morgan is out with its report today on CVS Caremark (NYSE: CVS), raising its PT from $42 to $43. In a note to clients, J.P. Morgan writes, "In our view, the FEP mail contract win is a significant positive for the company's PBM business. While we estimate the contract could add ~2% to EPS,...

Citigroup has raised the price target on CVS Caremark (NYSE: CVS) from $41 to $46 and maintains its Buy rating.

Weight Watchers (NYSE: WTW) is scheduled to report first-quarter 2011 results before the opening bell tomorrow, May 6. Analysts are looking for the weight loss specialist to announce that earnings came in at $0.89 per share. That compares to a consensus estimate of $0.60 some 90 days ago, and is up...

Goldman Sachs reported that, as the notion of a breakup of CVS into separate drugstore and PBM components gets more attention in the press (CNBC and Bloomberg last week), Goldman Sachs thinks it timely to revisit its investment thesis for the firm. “Our $40 12-month price target is based on 60%...

J.P. Morgan has issued a report on the fourth anniversary of the CVS Caremark (NYSE: CVS) merger. According to J.P. Morgan, “In our view, the strategy behind the merger is not inherently flawed, and we believe that Caremark has proven to be a valued asset to the retail pharmacy operation. As such...

J.P. Morgan is out with its report on CVS Caremark (NYSE: CVS), reiterating Overweight in anticipation of CVS reporting Q4 10 results this Thursday. In a note to clients, J.P. Morgan writes, "Overall, we believe CVS Caremark could deliver 4Q10 EPS at or above expectations, driven by potential...

CVS Caremark (NYSE: CVS) announced that it has appointed two of its senior Executives (Mike Bloom, EVP Merchandising and Supply Chain, and Scott Baker, EVP Internal Operations and Real Estate) as Interim Co-Presidents of CVS/Pharmacy, Citigroup reports. “Recall, that the company had originally...

Goldman Sachs has adjust price targets for the following companies: * Advance Auto Parts (NYSE: AAP) goes to $72 from $74. * CVS Caremark (NYSE: CVS) goes to $42 from $41. * Genuine Parts Company (NYSE: GPC) goes to $55 from $54. * O'Reilly Automotive (NASDAQ: ORLY) goes to $63 from $64. * Staples...

Citigroup has published a research report in anticipation of CVS Caremark Corporation's (NYSE: CVS) 2010 Analyst Day. In the report, Citigroup writes "CVS' new PBM marketing message is resonating well during the 2011 selling season and we believe CVS has had a good year in terms of renewals and new...